LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Share-based Compensation (2015 - 2026)

LivaNova's (LIVN) quarterly Share-based Compensation came in at $16.9 million in Q2 2026, up 138.97% year-over-year from $7.1 million in Q2 2025, and up 104.14% quarter-over-quarter from $8.3 million in Q1 2026.

Analysis

LivaNova (LIVN) Share-based Compensation (2015 - 2026) Analysis & Trends

LivaNova has disclosed Share-based Compensation across 12 years of filings, most recently posting $16.9 million for Q2 2026.

  • In Q2 2026, Share-based Compensation rose 138.97% year-over-year to $16.9 million; the TTM figure through Jun 2026 stood at $22.2 million (up 210.59% YoY), while the FY2025 annual figure was -$38.5 million, down 213.57% from the prior year.
  • Share-based Compensation came in at $16.9 million for Q2 2026 at LivaNova, up from $8.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $16.9 million in Q2 2026 to a low of -$43.3 million in Q2 2025.
  • Average Share-based Compensation over 5 years is $5.7 million, with a median of $9.4 million recorded in 2024.
  • Year-over-year, Share-based Compensation slumped 628.39% in 2025 and surged 138.97% in 2026.
  • Over 5 years, Share-based Compensation stood at $12.3 million in 2022, then tumbled by 32.75% to $8.3 million in 2023, then retreated by 16.11% to $6.9 million in 2024, then soared by 73.32% to $12.0 million in 2025, then surged by 40.17% to $16.9 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $16.9 million in Q2 2026, $8.3 million in Q1 2026, and $12.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 168.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 67.10 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 125.00 Mn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 7.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 61.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 42.20 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 42.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 39.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 12.80 Mn
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn 16.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.88 Mn
Mar 31, 2026 8.27 Mn
Dec 31, 2025 12.04 Mn
Sep 30, 2025 -15.04 Mn
Jun 30, 2025 -43.32 Mn
Mar 31, 2025 7.78 Mn
Dec 31, 2024 6.95 Mn
Sep 30, 2024 8.56 Mn
Jun 30, 2024 8.20 Mn
Mar 31, 2024 10.23 Mn
Dec 31, 2023 8.28 Mn
Sep 30, 2023 11.78 Mn
Jun 30, 2023 5.71 Mn
Mar 31, 2023 10.58 Mn
Dec 31, 2022 12.32 Mn
Sep 30, 2022 10.73 Mn
Jun 30, 2022 11.51 Mn
Mar 31, 2022 10.26 Mn
Dec 31, 2021 9.99 Mn
Sep 30, 2021 11.12 Mn